APhA Final Exam Questions With Correct
Answers
Which |of |the |following |is |true |for |live |attenuated |vaccines?
They |must |replicate |to |stimulate |an |immune |response.
Vaccines |should |be |delayed |for |which |of |the |following |patients?
A |patient |with |moderate |to |severe |acute |illness |that |requires |additional |care
Which |of |the |following |statements |is |true |about |risks |associated |with |vaccines |and |vaccine-
preventable |diseases?
International |travelers |import |many |cases |of |vaccine-preventable |diseases |into |the |United |
States |each |year.
Tasha |is |a |26-year-old |woman |with |rheumatoid |arthritis |who |is |treated |with |
immunosuppressive |therapy. |Which |of |the |following |vaccines |should |be |avoided |for |Tasha?
MMR
At |what |age |should |an |immunocompromised |patient |receive |the |recombinant |zoster |vaccine |
(RZV)?
19 |years
Which |of |the |following |is |a |provider |factor |associated |with |low |vaccination |rates |in |adults?
Lack |of |time |to |focus |on |preventive |services
The |majority |of |cases |of |vasovagal |syncope |occur |within |how |many |minutes |following |
vaccination?
15 |minutes
John |is |42 |and |was |diagnosed |with |HIV |2 |months |ago. |He |received |one |dose |of |MenACWY |at |
that |time |and |is |now |getting |his |2nd |dose. |Which |of |the |following |would |be |an |appropriate |
recommendation |for |MenACWY |vaccination |for |John?
Revaccinate |with |MenACWY |every |5 |years
What |is |the |concern |with |giving |inactivated |vaccines |to |patients |who |are |
immunocompromised?
They |may |not |be |as |effective.
, What |could |potentially |happen |if |an |intramuscular |vaccine |intended |for |the |deltoid |muscle |is |
administered |too |high?
Severe |shoulder |pain |and |injury
Which |of |the |following |sections |is |new |to |the |CDC |immunization |schedules?
Addendum
Mina |is |2 |years |old |and |just |received |her |first |dose |of |the |influenza |vaccine. |When |should |she |
return |for |her |next |dose?
4 |weeks
Which |of |the |following |is |the |routine |schedule |for |vaccinating |adolescents |with |MenACWY?
One |dose |at |age |11 |to |12 |years, |followed |by |a |booster |dose |at |age |16 |years
Which |of |the |following |vaccines |is |recommended |for |healthy |adolescents |and |adults |ages |16 |
through |23 |years |based |on |shared |clinical |decision-making?
Meningococcal |B
How |many |doses |of |the |15-valent |pneumococcal |conjugate |vaccine |(PCV15) |are |needed |to |
complete |the |routine |series |in |children |beginning |at |2 |months |of |age?
4
For |individuals |who |are |immunocompetent, |at |what |ages |can |the |2-dose |HPV |series |be |given?
9 |through |14 |years
Which |of |the |following |tetanus |toxoid-containing |vaccines |would |be |appropriate |for |a |15-
month |old |child?
DTaP
Larry |is |68 |years |old |and |has |a |new |grandbaby |on |the |way. |He |received |a |Td |vaccine |
approximately |13 |years |ago. |He |doesn't |know |if |he |received |any |tetanus |toxoid-containing |
vaccines |prior |to |that. |Which |of |the |following |tetanus |toxoid-containing |vaccines |would |be |
most |appropriate |to |recommend?
Tdap
Which |of |the |following |patients |would |be |an |appropriate |candidate |for |the |adjuvanted |
influenza |vaccine |(aIIV4)?
A |72 |year-old |woman |with |COPD
Answers
Which |of |the |following |is |true |for |live |attenuated |vaccines?
They |must |replicate |to |stimulate |an |immune |response.
Vaccines |should |be |delayed |for |which |of |the |following |patients?
A |patient |with |moderate |to |severe |acute |illness |that |requires |additional |care
Which |of |the |following |statements |is |true |about |risks |associated |with |vaccines |and |vaccine-
preventable |diseases?
International |travelers |import |many |cases |of |vaccine-preventable |diseases |into |the |United |
States |each |year.
Tasha |is |a |26-year-old |woman |with |rheumatoid |arthritis |who |is |treated |with |
immunosuppressive |therapy. |Which |of |the |following |vaccines |should |be |avoided |for |Tasha?
MMR
At |what |age |should |an |immunocompromised |patient |receive |the |recombinant |zoster |vaccine |
(RZV)?
19 |years
Which |of |the |following |is |a |provider |factor |associated |with |low |vaccination |rates |in |adults?
Lack |of |time |to |focus |on |preventive |services
The |majority |of |cases |of |vasovagal |syncope |occur |within |how |many |minutes |following |
vaccination?
15 |minutes
John |is |42 |and |was |diagnosed |with |HIV |2 |months |ago. |He |received |one |dose |of |MenACWY |at |
that |time |and |is |now |getting |his |2nd |dose. |Which |of |the |following |would |be |an |appropriate |
recommendation |for |MenACWY |vaccination |for |John?
Revaccinate |with |MenACWY |every |5 |years
What |is |the |concern |with |giving |inactivated |vaccines |to |patients |who |are |
immunocompromised?
They |may |not |be |as |effective.
, What |could |potentially |happen |if |an |intramuscular |vaccine |intended |for |the |deltoid |muscle |is |
administered |too |high?
Severe |shoulder |pain |and |injury
Which |of |the |following |sections |is |new |to |the |CDC |immunization |schedules?
Addendum
Mina |is |2 |years |old |and |just |received |her |first |dose |of |the |influenza |vaccine. |When |should |she |
return |for |her |next |dose?
4 |weeks
Which |of |the |following |is |the |routine |schedule |for |vaccinating |adolescents |with |MenACWY?
One |dose |at |age |11 |to |12 |years, |followed |by |a |booster |dose |at |age |16 |years
Which |of |the |following |vaccines |is |recommended |for |healthy |adolescents |and |adults |ages |16 |
through |23 |years |based |on |shared |clinical |decision-making?
Meningococcal |B
How |many |doses |of |the |15-valent |pneumococcal |conjugate |vaccine |(PCV15) |are |needed |to |
complete |the |routine |series |in |children |beginning |at |2 |months |of |age?
4
For |individuals |who |are |immunocompetent, |at |what |ages |can |the |2-dose |HPV |series |be |given?
9 |through |14 |years
Which |of |the |following |tetanus |toxoid-containing |vaccines |would |be |appropriate |for |a |15-
month |old |child?
DTaP
Larry |is |68 |years |old |and |has |a |new |grandbaby |on |the |way. |He |received |a |Td |vaccine |
approximately |13 |years |ago. |He |doesn't |know |if |he |received |any |tetanus |toxoid-containing |
vaccines |prior |to |that. |Which |of |the |following |tetanus |toxoid-containing |vaccines |would |be |
most |appropriate |to |recommend?
Tdap
Which |of |the |following |patients |would |be |an |appropriate |candidate |for |the |adjuvanted |
influenza |vaccine |(aIIV4)?
A |72 |year-old |woman |with |COPD
